logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: A randomized, sham-controlled trial by Prashant Singh & William D. Chey & Will Takakura & Brooks D. Cash & Brian E. Lacy & Eamonn M.M. Quigley & Charles W. Randall & Anthony Lembo instant download

  • SKU: EBN-236509036
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

0.0

0 reviews
Instant download (eBook) A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: A randomized, sham-controlled trial after payment.
Authors:Prashant Singh & William D. Chey & Will Takakura & Brooks D. Cash & Brian E. Lacy & Eamonn M.M. Quigley & Charles W. Randall & Anthony Lembo
Pages:updating ...
Year:2025
Publisher:x
Language:english
File Size:1.02 MB
Format:pdf
Categories: Ebooks

Product desciption

A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: A randomized, sham-controlled trial by Prashant Singh & William D. Chey & Will Takakura & Brooks D. Cash & Brian E. Lacy & Eamonn M.M. Quigley & Charles W. Randall & Anthony Lembo instant download

Gastroenterology, Journal Pre-proof. doi:10.1053/j.gastro.2025.01.223

Background & Aims: Personalized dietary therapies for irritable bowel syndrome (IBS)are needed and an IgG-antibody-based elimination diet presents a potential solution. However, existing studies have serious methodological limitations. This study aimed to assess the efficacy of an elimination diet utilizing a novel IBS-specific IgG assay.Methods: We conducted a randomized, double-blind, sham-controlled trial enrolling subjects with IBS from 8 centers. Subjects positive for ≥1 food on an 18-food IgG assay and an average daily abdominal pain intensity (API) score between 3-7.5 on an 11-point scale during a 2-week run-in period were randomized to either an experimental antibody-guided diet or sham diet for 8 weeks. The primary outcome was a ≥30% decrease in API for ≥2 of the last 4 weeks of the treatment period. Results: Among 238 randomized IBS subjects, 223 were included in the modified intention-to-treat analysis. A significantly greater proportion of subjects in the experimental diet group met the primary outcome than those in the sham diet group (59.6% vs. 42.1%, P=0.02). Subgroup analysis revealed that a higher proportion of IBSC and IBS-M subjects in the experimental diet group met the primary endpoint vs. the sham group (67.1% vs. 35.8% and 66% vs. 29.5%, respectively). Conclusions: Subjects on an IgG-guided elimination diet were more likely to achieve the primary endpoint than those on a sham elimination diet. Subgroup analysis suggests a more robust benefit for subjects with IBS-C and IBS-M. This highlights the potential effectiveness of a personalized elimination diet based on a novel IBS-specificIgG assay. A larger study is warranted to validate these observations. ClinicalTrials.gov number, NCT03459482Keywords: functional bowel disorder, precision medicine, bloating, IBS with diarrhea, bowel habits, disorders of gut-brain interaction

*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products